Neumora Therapeutics, Inc.
NMRA
Revenue
0.00
0.000.00%
-Assets
404.47M
▼-45.74M▼-10.16%
3 Months ChangeLiabilities
23.21M
▼-2.46M▼-9.56%
3 Months ChangeFree Cash Flow
-33.08M
▼-33.08M-∞%
-Revenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-08-06
Form 10-Q
ID: 0000950170-24-091737
2024-08-06
Form 8-K
ID: 0000950170-24-091205
2024-06-14
Form 8-K
ID: 0001193125-24-161572
2024-05-07
Form 10-Q
ID: 0000950170-24-054448
2024-05-07
Form 8-K
ID: 0000950170-24-053933
2024-04-15
Form 8-K
ID: 0001193125-24-095472
2024-03-07
Form 8-K
ID: 0001193125-24-061473
2024-01-08
Form 8-K
ID: 0001193125-24-003968
2023-11-28
Form 8-K
ID: 0001193125-23-284303
2023-11-01
Form 10-Q
ID: 0000950170-23-057424